The Biological Function of M6A Reader YTHDF2 and Its Role in Human Disease

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2021 Feb 17

PMID 33593354

Citations 48

Authors

Jin-Yan Wang

Ai-Qing Lu

Affiliations

Soon will be listed here.

Abstract

N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional modification and the most prevalent internal RNA modification in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) is a member of m6A "readers" and its role in human diseases remains unclear. Accumulating evidence suggests that YTHDF2 is greatly implicated in many aspects of human cancers and non-cancers through various mechanisms. YTHDF2 takes a great part in multiple biological processes, such as migration, invasion, metastasis, proliferation, apoptosis, cell cycle, cell viability, cell adhesion, differentiation and inflammation, in both human cancers and non-cancers. Additionally, YTHDF2 influences various aspects of RNA metabolism, including mRNA decay and pre-ribosomal RNA (pre-rRNA) processing. Moreover, emerging researches indicate that YTHDF2 predicts the prognosis of different cancers. Herein, we focus on concluding YTHDF2-associated mechanisms and potential biological functions in kinds of cancers and non-cancers, and its prospects as a prognostic biomarker.

Citing Articles

Silencing YTHDF2 Induces Apoptosis of Neuroblastoma Cells In a Cell Line-Dependent Manner via Regulating the Expression of DLK1.

Hua Z, Gong B, Li Z Mol Neurobiol. 2025; .

PMID: 39979690 DOI: 10.1007/s12035-025-04759-y.

RNA modifications in cancer.

Wu H, Chen S, Li X, Li Y, Shi H, Qing Y MedComm (2020). 2025; 6(1):e70042.

PMID: 39802639 PMC: 11718328. DOI: 10.1002/mco2.70042.

Liquid-liquid phase separation in hepatocellular carcinoma.

Xu J, Liu W, Yao Y, Knowles T, Zhang Z, Zhang Y Front Cell Dev Biol. 2025; 12():1454587.

PMID: 39777266 PMC: 11703843. DOI: 10.3389/fcell.2024.1454587.

m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway.

Huang T, Ao X, Liu J, Sun C, Dong Y, Yin X Transl Oncol. 2024; 51:102230.

PMID: 39626341 PMC: 11652952. DOI: 10.1016/j.tranon.2024.102230.

RNA m6A methylation regulatory mechanism of resveratrol in premature senescence cells.

Zhang X, Zhu C, Zhang L, Tan L, Cheng W, Li M Food Sci Nutr. 2024; 12(11):9238-9251.

PMID: 39619978 PMC: 11606896. DOI: 10.1002/fsn3.4487.

References

Li M, Zhao X, Wang W, Shi H, Pan Q, Lu Z . Ythdf2-mediated mA mRNA clearance modulates neural development in mice. Genome Biol. 2018; 19(1):69. PMC: 5984442. DOI: 10.1186/s13059-018-1436-y. View

Ke S, Alemu E, Mertens C, Gantman E, Fak J, Mele A . A majority of m6A residues are in the last exons, allowing the potential for 3' UTR regulation. Genes Dev. 2015; 29(19):2037-53. PMC: 4604345. DOI: 10.1101/gad.269415.115. View

Hesser C, Karijolich J, Dominissini D, He C, Glaunsinger B . N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog. 2018; 14(4):e1006995. PMC: 5919695. DOI: 10.1371/journal.ppat.1006995. View

Yang J, Han Q, Li C, Yang H, Chen X, Wang X . Circular RNA circ_0001105 Inhibits Progression and Metastasis of Osteosarcoma by Sponging miR-766 and Activating YTHDF2 Expression. Onco Targets Ther. 2020; 13:1723-1736. PMC: 7051899. DOI: 10.2147/OTT.S234668. View

Wang H, Xu B, Shi J . N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2019; 722:144076. DOI: 10.1016/j.gene.2019.144076. View

Li Z, Luo Q, Wang H, Liu Y, Feng X, Li Z . [Knockdown of YTH N-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020; 36(3):255-263. View

Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H . Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019; 35(4):677-691.e10. PMC: 6812656. DOI: 10.1016/j.ccell.2019.03.006. View

Cai M, Liu Q, Jiang Q, Wu R, Wang X, Wang Y . Loss of m A on FAM134B promotes adipogenesis in porcine adipocytes through m A-YTHDF2-dependent way. IUBMB Life. 2018; 71(5):580-586. DOI: 10.1002/iub.1974. View

Zhang J, Pi J, Liu Y, Yu J, Feng T . [Knockdown of YTH N-methyladenosine RNA binding protein 2 (YTHDF2) inhibits proliferation and promotes apoptosis in MGC-803 gastric cancer cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018; 33(12):1628-1634. View

10.

Li Z, Weng H, Su R, Weng X, Zuo Z, Li C . FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N-Methyladenosine RNA Demethylase. Cancer Cell. 2016; 31(1):127-141. PMC: 5234852. DOI: 10.1016/j.ccell.2016.11.017. View

11.

Xu X, Yu Y, Zong K, Lv P, Gu Y . Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2019; 38(1):497. PMC: 6921559. DOI: 10.1186/s13046-019-1470-y. View

12.

Gonzales-van Horn S, Sarnow P . Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses. Cell Host Microbe. 2017; 21(6):661-669. PMC: 5555051. DOI: 10.1016/j.chom.2017.05.008. View

13.

Walasek M, van Os R, de Haan G . Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci. 2012; 1266:138-50. DOI: 10.1111/j.1749-6632.2012.06549.x. View

14.

Huang T, Liu Z, Zheng Y, Feng T, Gao Q, Zeng W . YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via mA/mRNA pathway. Cell Death Dis. 2020; 11(1):37. PMC: 6971064. DOI: 10.1038/s41419-020-2235-4. View

15.

Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K . YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020; 39(23):4507-4518. DOI: 10.1038/s41388-020-1303-7. View

16.

Kanatsu-Shinohara M, Shinohara T . Spermatogonial stem cell self-renewal and development. Annu Rev Cell Dev Biol. 2013; 29:163-87. DOI: 10.1146/annurev-cellbio-101512-122353. View

17.

Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, Liu Q . mA methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner. Cell Death Dis. 2019; 10(3):171. PMC: 6382841. DOI: 10.1038/s41419-019-1417-4. View

18.

Jin D, Guo J, Wu Y, Yang L, Wang X, Du J . mA demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020; 19(1):40. PMC: 7045432. DOI: 10.1186/s12943-020-01161-1. View

19.

Zhu H, Gan X, Jiang X, Diao S, Wu H, Hu J . ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2. J Exp Clin Cancer Res. 2019; 38(1):163. PMC: 6463658. DOI: 10.1186/s13046-019-1159-2. View

20.

Zhu T, Roundtree I, Wang P, Wang X, Wang L, Sun C . Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine. Cell Res. 2014; 24(12):1493-6. PMC: 4260350. DOI: 10.1038/cr.2014.152. View